S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Urgent Warning (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Urgent Warning (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Urgent Warning (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Urgent Warning (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:SGRY

Surgery Partners - SGRY Competitors

$31.59
-0.06 (-0.19%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$30.78
$31.63
50-Day Range
$30.11
$35.94
52-Week Range
$20.46
$63.87
Volume
575,125 shs
Average Volume
686,932 shs
Market Capitalization
$3.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.00

SGRY vs. THC, UHS, BRBR, MMSI, TDOC, NEOG, HAE, MDGL, ALKS, and CERT

Should you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Tenet Healthcare (THC), Universal Health Services (UHS), BellRing Brands (BRBR), Merit Medical Systems (MMSI), Teladoc Health (TDOC), Neogen (NEOG), Haemonetics (HAE), Madrigal Pharmaceuticals (MDGL), Alkermes (ALKS), and Certara (CERT). These companies are all part of the "medical" sector.

Surgery Partners vs.

Surgery Partners (NASDAQ:SGRY) and Tenet Healthcare (NYSE:THC) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations.

Surgery Partners has a beta of 2.73, suggesting that its share price is 173% more volatile than the S&P 500. Comparatively, Tenet Healthcare has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500.

98.1% of Tenet Healthcare shares are owned by institutional investors. 3.3% of Surgery Partners shares are owned by company insiders. Comparatively, 1.7% of Tenet Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Surgery Partners presently has a consensus target price of $42.00, indicating a potential upside of 32.95%. Tenet Healthcare has a consensus target price of $69.47, indicating a potential upside of 27.49%. Given Surgery Partners' higher possible upside, analysts clearly believe Surgery Partners is more favorable than Tenet Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Tenet Healthcare
0 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
3.00

Tenet Healthcare received 334 more outperform votes than Surgery Partners when rated by MarketBeat users. Likewise, 59.46% of users gave Tenet Healthcare an outperform vote while only 57.91% of users gave Surgery Partners an outperform vote.

CompanyUnderperformOutperform
Surgery PartnersOutperform Votes
282
57.91%
Underperform Votes
205
42.09%
Tenet HealthcareOutperform Votes
616
59.46%
Underperform Votes
420
40.54%

In the previous week, Surgery Partners and Surgery Partners both had 3 articles in the media. Surgery Partners' average media sentiment score of 0.70 beat Tenet Healthcare's score of 0.49 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tenet Healthcare
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tenet Healthcare has a net margin of 2.14% compared to Surgery Partners' net margin of -2.15%. Tenet Healthcare's return on equity of 32.88% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners -2.15% -0.14% -0.05%
Tenet Healthcare 2.14% 32.88% 2.79%

Tenet Healthcare has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Tenet Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$2.54 billion1.57-$54.60 million-$0.58-54.47
Tenet Healthcare$19.17 billion0.29$411 million$3.7114.69

Summary

Tenet Healthcare beats Surgery Partners on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGRY vs. The Competition

MetricSurgery PartnersGeneral medical & surgical hospitals IndustryMedical SectorNASDAQ Exchange
Market Cap$3.98B$11.16B$4.34B$5.89B
Dividend YieldN/A0.79%2.39%4.41%
P/E Ratio-54.479.22153.2415.53
Price / Sales1.570.613,472.7260.89
Price / Cash37.3511.8327.45103.34
Price / Book1.351.194.474.95
Net Income-$54.60M$839.43M$115.09M$190.72M
7 Day Performance1.09%-1.10%-0.82%0.70%
1 Month Performance-6.23%-9.50%-6.59%-6.02%
1 Year Performance-41.25%-23.99%-16.04%-18.22%

Surgery Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THC
Tenet Healthcare
2.8754 of 5 stars
$56.36
-2.8%
$69.47
+23.3%
-38.6%$5.76B$19.17B15.19102,400Analyst Upgrade
UHS
Universal Health Services
2.4652 of 5 stars
$122.24
-2.9%
$131.29
+7.4%
-16.2%$8.64B$13.40B13.3693,800Analyst Downgrade
BRBR
BellRing Brands
2.8597 of 5 stars
$29.99
-1.9%
$33.40
+11.4%
+44.3%$4.01B$1.37B33.70355Analyst Upgrade
News Coverage
MMSI
Merit Medical Systems
1.9455 of 5 stars
$70.52
-0.4%
$76.33
+8.2%
+15.7%$4.04B$1.15B54.256,846
TDOC
Teladoc Health
2.4054 of 5 stars
$24.49
-4.7%
$34.72
+41.8%
-63.9%$3.98B$2.41B-0.295,600
NEOG
Neogen
1.1019 of 5 stars
$18.35
-3.0%
$20.00
+9.0%
-41.3%$3.97B$527.16M367.001,039Upcoming Earnings
HAE
Haemonetics
2.5611 of 5 stars
$77.31
-3.4%
$101.00
+30.6%
+33.5%$3.90B$1.13B41.792,821
MDGL
Madrigal Pharmaceuticals
2.5379 of 5 stars
$231.06
-5.9%
$294.75
+27.6%
+144.5%$4.19BN/A-13.4171
ALKS
Alkermes
1.7555 of 5 stars
$25.83
-2.6%
$30.11
+16.6%
-0.3%$4.25B$1.11B-26.912,280Analyst Upgrade
News Coverage
CERT
Certara
1.8117 of 5 stars
$23.59
-4.6%
$22.43
-4.9%
+7.9%$3.76B$335.64M262.141,204
This page (NASDAQ:SGRY) was last updated on 3/25/2023 by MarketBeat.com Staff